Wolverine Asset Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Wolverine Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Wolverine Asset Management from 13F filings

Historical chart of Wolverine Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Wolverine Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Wolverine Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $23M 19M 1.19
2024-06-30 $52M 47M 1.11
2024-03-31 $50M 51M 0.98
2023-12-31 $48M 51M 0.93
2023-09-30 $48M 51M 0.94

More positions owned by Wolverine Asset Management

Microstrategy Cl A New Call Option (MSTR)
Coinbase Global Com Cl A Put Option (COIN)
Rivian Automotive Com Cl A Put Option (RIVN)
Draftkings Note 3/1 (Principal)
Royal Caribbean Cruises Put Option (RCL)
Sea Note 2.375%12/0 (Principal)
Zillow Group Note 1.375% 9/0 (Principal)
Nio Spon Ads Put Option (NIO)
Li Auto Note 0.250% 5/0 (Principal)
Cytokinetics Note 3.500% 7/0 (Principal)
Airbnb Note 3/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Coinbase Global Note 0.500% 6/0 (Principal)
Conmed Corp Note 2.250% 6/1 (Principal)
Zto Express Cayman Note 1.500% 9/0 (Principal)

View all positions for Wolverine Asset Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1